Tower Research Capital LLC (Trc) Invo Bioscience, Inc. Transaction History

Tower Research Capital LLC (Trc)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.16 - $0.64 $5 - $23	-36 Reduced 0.37%	9,713 $1,000
Q1 2023 May 09, 2023	SELL	$0.44 - $0.81 $4 - $8	-11 Reduced 0.11%	9,749 $6,000
Q4 2022 Feb 10, 2023	SELL	$0.39 - $28.0 $455 - $32,704	-1,168 Reduced 10.69%	9,760 $4,000
Q3 2022 Nov 10, 2022	SELL	$0.77 - $23.2 $2,075 - $62,547	-2,696 Reduced 19.79%	10,928 $12,000
Q2 2022 Aug 15, 2022	BUY	$0.64 - $2.66 $7,098 - $29,502	11,091 Added 437.86%	13,624 $9,000
Q1 2022 May 12, 2022	BUY	$2.19 - $3.82 $5,547 - $9,676	2,533 New	2,533 $7,000
Q4 2021 Feb 14, 2022	SELL	$2.93 - $4.19 $2,824 - $4,039	-964 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.17 - $4.61 $1,645 - $2,392	519 Added 116.63%	964 $3,000
Q2 2021 Aug 16, 2021	SELL	$3.71 - $5.18 $1,023 - $1,429	-276 Reduced 38.28%	445 $2,000
Q1 2021 May 17, 2021	BUY	$2.96 - $9.4 $2,134 - $6,777	721 New	721 $3,000

14.1K

Ticker INVO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,169,700
Market Cap $9.86M
Description
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.